Related references
Note: Only part of the references are listed.CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
Xueqing Sun et al.
CANCER AND METASTASIS REVIEWS (2010)
The Peptidomimetic CXCR4 Antagonist TC14012 Recruits β-Arrestin to CXCR7 ROLES OF RECEPTOR DOMAINS
Stephanie Gravel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis
M. Tessema et al.
ONCOGENE (2010)
CXCL12 Chemokine Expression and Secretion Regulates Colorectal Carcinoma Cell Anoikis through Bim-Mediated Intrinsic Apoptosis
Luke J. Drury et al.
PLOS ONE (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
Diversity in arrestin function
Ryan T. Kendall et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Chemokine Receptors as Targets for Cancer Therapy
Xuesong Wu et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Differential Activation and Regulation of CXCR1 and CXCR2 by CXCL8 Monomer and Dimer
Mohd W. Nasser et al.
JOURNAL OF IMMUNOLOGY (2009)
Functional Selectivity of Natural and Synthetic Prostaglandin EP4 Receptor Ligands
Martin Leduc et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
OPINION Chemokine receptor antagonists: overcoming developmental hurdles
Richard Horuk
NATURE REVIEWS DRUG DISCOVERY (2009)
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
David A. Zidar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CXCR4 dimerization and β-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome
Bernard Lagane et al.
BLOOD (2008)
Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells
Michael K. Wendt et al.
GASTROENTEROLOGY (2008)
Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12
Christopher T. Veldkamp et al.
SCIENCE SIGNALING (2008)
Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells
M. K. Wendt et al.
ONCOGENE (2008)
On-column refolding of recombinant chemokines for NMR studies and biological assays
Christopher T. Veldkamp et al.
PROTEIN EXPRESSION AND PURIFICATION (2007)
Clinical utilization of chemokines to combat cancer: the double-edged sword
Chiara Dell'Agnola et al.
EXPERT REVIEW OF VACCINES (2007)
Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases
Chih-hung Lee et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis
M. K. Wendt et al.
ONCOGENE (2006)
Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1α (SDF-1α/CXCL12)
Christopher T. Veldkamp et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Adenoviral gene transfer of stromal cell-derived factor-1 to Murine tumors induces the accumulation of dendritic cells and suppresses tumor growth
T Fushimi et al.
CANCER RESEARCH (2006)
The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
K Balabanian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin
CT Veldkamp et al.
PROTEIN SCIENCE (2005)
Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers
Y Percherancier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity
JM Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
SDF-1/CXCL12 regulates cAMP production and ion transport in intestinal epithelial cells via CXCR4
MB Dwinell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies
RJ Epstein
NATURE REVIEWS CANCER (2004)
β-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation
Y Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Defective lymphocyte chemotaxis in β-arresting2-and GRK6-deficient mice
AM Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Chemokines and the molecular basis of cancer metastasis.
PM Murphy
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Share Paper
